Prostatis Group’s Vanguard Morningstar Large-Cap ETF VV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,110
Closed -$332K 204
2026
Q1
$332K Sell
1,110
-256
-19% -$80.1K 0.08% 129
2025
Q4
$430K Sell
1,366
-18
-1% -$5.62K 0.1% 110
2025
Q3
$426K Buy
1,384
+97
+8% +$28.7K 0.11% 104
2025
Q2
$367K Buy
+1,287
New +$339K 0.11% 109
2024
Q3
Sell
-3,338
Closed -$833K 156
2024
Q2
$833K Sell
3,338
-226
-6% -$54.3K 0.29% 72
2024
Q1
$855K Sell
3,564
-2,516
-41% -$576K 0.32% 69
2023
Q4
$1.33M Sell
6,080
-789
-11% -$161K 0.55% 50
2023
Q3
$1.34M Sell
6,869
-90,298
-93% -$18.4M 0.66% 36
2023
Q2
$1.4M Buy
97,167
+90,287
+1,312% +$17.3M 0.65% 38
2023
Q1
$1.3M Buy
6,880
+4,181
+155% +$761K 0.68% 36
2022
Q4
$470K Buy
+2,699
New +$474K 0.29% 65

Other funds holding VV

Prostatis Group's VV Position: Q2 2026 in Review

Prostatis Group sold out of Vanguard Morningstar Large-Cap ETF (VV) in Q2 2026, closing a stake of 1,110 shares — an estimated $332K sold.

Prostatis Group first reported a position in VV in Q4 2022 and held it in 11 quarters. The position peaked at $1.4M in Q2 2023. 1,369 funds tracked by Wall St. Rank hold VV as of Q2 2026.

  • Prostatis Group reported no remaining Vanguard Morningstar Large-Cap ETF position as of Q2 2026 after selling out during the quarter.
  • Prostatis Group sold 1,110 Vanguard Morningstar Large-Cap ETF shares in Q2 2026, an estimated $332K.
  • Prostatis Group first reported a position in Vanguard Morningstar Large-Cap ETF in Q4 2022 and held it in 11 quarters.
  • Prostatis Group's Vanguard Morningstar Large-Cap ETF position peaked at $1.4M in Q2 2023.
  • 1,369 funds tracked by Wall St. Rank held Vanguard Morningstar Large-Cap ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.